These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 15301577

  • 1. Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder.
    Ravindran A, Silverstone P, Lacroix D, van Schaick E, Vermeulen A, Alexander J.
    Clin Pharmacokinet; 2004; 43(11):733-40. PubMed ID: 15301577
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
    Casey DE, Daniel DG, Wassef AA, Tracy KA, Wozniak P, Sommerville KW.
    Neuropsychopharmacology; 2003 Jan; 28(1):182-92. PubMed ID: 12496955
    [Abstract] [Full Text] [Related]

  • 4. Tolerability of oral loading of divalproex sodium in the treatment of acute mania.
    Martinez JM, Russell JM, Hirschfeld RM.
    Depress Anxiety; 1998 Jan; 7(2):83-6. PubMed ID: 9614597
    [Abstract] [Full Text] [Related]

  • 5. Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.
    Tohen M, Vieta E, Goodwin GM, Sun B, Amsterdam JD, Banov M, Shekhar A, Aaronson ST, Bardenstein L, Grecu-Gabos I, Tochilov V, Prelipceanu D, Oliff HS, Kryzhanovskaya L, Bowden C.
    J Clin Psychiatry; 2008 Nov; 69(11):1776-89. PubMed ID: 19014751
    [Abstract] [Full Text] [Related]

  • 6. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL.
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [Abstract] [Full Text] [Related]

  • 7. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS, Mancini DA, Srinivasan J, McCann S, Konarski JZ, Kennedy SH.
    Can J Clin Pharmacol; 2004 Jul; 11(2):e218-26. PubMed ID: 15520475
    [Abstract] [Full Text] [Related]

  • 8. Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder.
    Pavuluri MN, Henry DB, Findling RL, Parnes S, Carbray JA, Mohammed T, Janicak PG, Sweeney JA.
    Bipolar Disord; 2010 Sep; 12(6):593-605. PubMed ID: 20868458
    [Abstract] [Full Text] [Related]

  • 9. A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.
    Wagner KD, Redden L, Kowatch RA, Wilens TE, Segal S, Chang K, Wozniak P, Vigna NV, Abi-Saab W, Saltarelli M.
    J Am Acad Child Adolesc Psychiatry; 2009 May; 48(5):519-532. PubMed ID: 19325497
    [Abstract] [Full Text] [Related]

  • 10. Treatment of Early-Age Mania: Outcomes for Partial and Nonresponders to Initial Treatment.
    Walkup JT, Wagner KD, Miller L, Yenokyan G, Luby JL, Joshi PT, Axelson DA, Robb A, Salpekar JA, Wolf D, Sanyal A, Birmaher B, Vitiello B, Riddle MA.
    J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):1008-19. PubMed ID: 26598476
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of switching psychiatric patients from a delayed-release to an extended-release formulation of divalproex sodium.
    Horne RL, Cunanan C.
    J Clin Psychopharmacol; 2003 Apr; 23(2):176-81. PubMed ID: 12640219
    [Abstract] [Full Text] [Related]

  • 12. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [Abstract] [Full Text] [Related]

  • 13. Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia.
    Casey DE, Daniel DG, Tamminga C, Kane JM, Tran-Johnson T, Wozniak P, Abi-Saab W, Baker J, Redden L, Greco N, Saltarelli M.
    Neuropsychopharmacology; 2009 Apr; 34(5):1330-8. PubMed ID: 19052541
    [Abstract] [Full Text] [Related]

  • 14. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial.
    Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A.
    Br J Psychiatry; 2003 Feb; 182():141-7. PubMed ID: 12562742
    [Abstract] [Full Text] [Related]

  • 15. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents.
    Geller B, Luby JL, Joshi P, Wagner KD, Emslie G, Walkup JT, Axelson DA, Bolhofner K, Robb A, Wolf DV, Riddle MA, Birmaher B, Nusrat N, Ryan ND, Vitiello B, Tillman R, Lavori P.
    Arch Gen Psychiatry; 2012 May; 69(5):515-28. PubMed ID: 22213771
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combination of Olanzapine and Samidorphan Has No Clinically Significant Effect on the Pharmacokinetics of Lithium or Valproate.
    Sun L, Yagoda S, Yao B, Graham C, von Moltke L.
    Clin Drug Investig; 2020 Jan; 40(1):55-64. PubMed ID: 31584140
    [Abstract] [Full Text] [Related]

  • 18. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group.
    Müller-Oerlinghausen B, Retzow A, Henn FA, Giedke H, Walden J.
    J Clin Psychopharmacol; 2000 Apr; 20(2):195-203. PubMed ID: 10770458
    [Abstract] [Full Text] [Related]

  • 19. Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study.
    Bahk WM, Shin YC, Woo JM, Yoon BH, Lee JS, Jon DI, Chung SK, Choi SK, Paik IH, Pae CU.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):115-21. PubMed ID: 15610953
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME.
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.